tbuckley/cabot-search huggingface dataset:
Natural orifice transluminal endoscopic surgery (NOTES)
Authors: S. von Delius, A. Meining
Journal: Endoscopy (2010)

Natural orifice transluminal endoscopic surgery (NOTES) is still a matter of scientific research, and indeed, the total number of peer-reviewed original papers published on NOTES has increased recently compared with previous years. This holds true for all types of NOTES-related research topics ([Fig. 1]).
Prolonged survival after kidney transplantation. Report of a case five years after transplantation from an unrelated donor
Authors: J. J. Kaufman
Journal: JAMA (1969)

The recipient of a kidney transplant from an unrelated donor survived for 5 1/2 years. Following the transplantation, the patient withstood several serious insults, including barbiturate intoxication and a myocardial infarcion. He was losing renal function during the sixth year after the transplantation and was considered for a second graft, but, unfortunately, he died of a second myocardial infarction.
Deaths
Journal: JAMA (1918)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Infection control practices in Minnesota nursing homes
Authors: K. B. Crossley
Journal: JAMA (1985)

Because infection is a major cause of hospitalization among nursing home residents, we assessed infection control activities and related employee health policies in Minnesota nursing homes, using a questionnaire. The majority of institutions (378/440, 85.9%) responded. We found traditional isolation techniques were widely used, but blood and urine precautions were employed in less than half of the homes. Infection surveillance tended to focus on chart review. Antibiotic utilization studies were done in 76% of homes. Procedures for urinary catheter care were often at variance with current recommendations. Employee health policies required a physical examination of a new employee in a minority of institutions. Policies required by Minnesota statute (eg, skin testing for tuberculosis and documentation of employee illness) were carried out by most institutions. Infection control policies and procedures in nursing homes should be redefined so that, where appropriate, they are more consistent with practices in acute-care hospitals. (<i>JAMA</i>1985;254:2918-2921)
THE MARTYRED MEAL
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The bile acid derivative norursodeoxycholic acid affects fatty-liver associated anhedonia and anxiety in mice
Authors: Daniel Steinacher, Johannes Grießner, Claudia Fuchs, Lorenz Hinterleitner, Maximilian Baumgratner, Joanna Kaczanowska, Florian Grössl, Andreas Hess, Wulf Haubensak, Michael Trauner
Journal: Journal of Hepatology (2020)
Oral minoxidil in the treatment of hypertensive crisis
Authors: B. C. Wood
Journal: JAMA (1979)

WITH the advent of aggressive antihypertensive therapy, the mortality of patients with malignant hypertension has been drastically reduced. Because of new forms of drug therapy, bilateral nephrectomy, once recommended for severe and controlled hypertension, is no longer indicated.<sup>1</sup>In fact, studies often indicate improvement in renal function once control of blood pressure (BP) is obtained.<sup>2</sup> Parenteral drugs such as diazoxide and sodium nitroprusside have replaced slower, less predictably acting antihypertensives for the rapid lowering of BP. However, if the patient fails to respond to these drugs, he still faces nephrectomy as a therapeutic choice. We report the case of a patient who failed to respond to high doses of sodium nitroprusside but had a rapid lowering of BP following oral administration of minoxidil, an experimental vasodilator used principally for the control of chronic refractory hypertension.<sup>3</sup> <h3>Report of a Case</h3> A 15-year-old girl was referred to a neurosurgeon
NEEDLE FOR IRRIGATION OF THE ANTRUM
Journal: JAMA (1929)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Book Review Clinical Diagnosis by Laboratory Methods . (Seventh Edition.) By James Campbell Todd, Ph.B., M.D., Late Professor of Clinical Pathology, University of Colorado, School of Medicine; and Arthur Hawley Sanford, A.M., M.D., Professor of Clinical Pathology, University of Minnesota (Mayo Foundation); Head of Section on Clinical Laboratories, Mayo Clinic. Seventh Edition, Thoroughly Revised, 765 Pages with 347 Illustrations, 29 in colors. Philadelphia and London: W. B. Saunders Company, …
Journal: New England Journal of Medicine (1931)
AMG 510 First to Inhibit “Undruggable” KRAS
Journal: Cancer Discovery (2019)

Amgen's novel small-molecule inhibitor AMG 510 has become the first drug to successfully target a KRAS mutation in patients, according to findings presented at the 2019 American Society of Clinical Oncology Annual Meeting. In a phase I trial, AMG 510 elicited partial responses in half of evaluable patients with KRASG12C-mutant non-small cell lung cancer, and led to stable disease in most evaluable patients with colorectal or appendix cancer.
Diathermy: Short Wave Therapy, Inductothermy, Epithermy
Journal: JAMA (1941)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Granulocytopenia occurring during the administration of lincomycin
Authors: E. B. Brown
Journal: JAMA (1965)

DURING the evaluation of the clinical effectiveness of the use of lincomycin, granulocytopenia developed coincidentally in an adult patient. Of the thousands of persons in whom the drug was used during this nationwide investigation, three newborns were reported to have similar findings (personal communication from J. B. Lawson, Upjohn Pharmaceutical Co., Aug 10, 1964). Since the Food and Drug Administration has used this event as its basis for requiring the manufacturer to state that lincomycin might cause granulocytopenia, we thought it incumbent upon ourselves to report this case. <h3>Report of a Case</h3> A 37-year-old Negro woman was hospitalized at Misericordia Hospital on Dec 17, 1963 because of chills, fever, dyspnea, and a cough of three days' duration, productive of moderate quantities of purulent sputum. She stated that she had been in her usual state of health until seven days before admission when she noted the onset of cough and general
Medicine
Authors: Omar A. Khan
Journal: JAMA (2006)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Hepatic Nuclear Ploidy Distribution of Dietary-Restricted Mice
Authors: Ming H. Lu, William G. Hinson, Dansha He, Angelo Turturro, Ronald W. Hart
Journal: Environmental Health Perspectives (1993)

Hepatic parenchymal cells in most adult mammals are polyploid, with most of the cells in the quiescent or low-proliferation state.Polyploidization has been related to carcinogenesis and aging, and both end points are significantly affected by dietary restriction (DR).Direct mea- sures of hepatic nuclear polyploidization in DR B6C3F, mice have not been examined.We exam- ined the effect of DR on distributions of nuclear ploidy in both sexes and on different age groups of R6C3F, mice.Differences between young and old male mice and between old male and female mice were also compared.Hepatic nuclear ploidy values were measured by flow cytometry.The DNA histograms were analyzed for the percentage of nuclei having different classes of DNA content by gating channels between the areas under the peaks of diploid, tetraploid, and octaploid.The results indicate that 1 or 26 months of DR started at 4 months of age did not alter hepatic nuclear ploidy distributions in young and old mice.Our data suggest that in the male mouse, polyploidization is established by 5 months of age for hepatic nuclei and that ploidy classes are affected by sex at 30 months of age.For females, effects in the octa- ploid nuclei are seen as a result of DR.
219 The risk of adverse reactions (AR) from percutaneous prick-puncture allergen skin testing (ST), venipuncture (VP), and body measurements (BM): Data from the second national health and nutrition examination survey, 1976–1980 (NHANES II)
Authors: M. White, P.J. Gergen, P.C. Turkeltaub
Journal: Journal of Allergy and Clinical Immunology (1988)
Metabolic effects of repeated weight loss and regain in adolescent wrestlers
Authors: S. N. Steen
Journal: JAMA (1988)

This study examined resting metabolic rate in adolescent wrestlers to test the hypothesis that repeated cycles of weight loss and regain would be associated with reduced energy requirements. Energy restriction lowers resting metabolic rate in normal-weight and obese persons. Repeated cycles of weight loss and regain can increase food efficiency, defined as the degree of weight change per unit of food intake, in animals. Many wrestlers lose weight repeatedly as they "cut weight" for matches. This cycle of weight loss and regain may affect their resting metabolism. Twenty-seven wrestlers were classified as cyclers or noncyclers based on their weight loss history. Resting metabolic rate was measured using indirect calorimetry and body composition was evaluated using six skinfolds. Cyclers and noncyclers did not differ in age, weight, height, surface area, lean body mass, or percent body fat. Cyclers had a significantly lower mean resting metabolic rate than noncyclers (154.6 vs 177.2 kJ/m<sup>2</sup>/h) (4.6 vs 5.5 kJ per kilogram of lean body mass per hour). There was a 14% difference between the cyclers and the noncyclers in resting energy expenditure (6631.8 vs 7702.8 kJ/d). Weight cycling in wrestlers appears to be associated with a lowered resting metabolic rate. (<i>JAMA</i>1988;260:47-50)
International Abstracts
Journal: JAMA (1991)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
PHYSICIANS FOR CORONERS.
Journal: JAMA (1890)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Chlorpropamide-induced hypoglycemia. A dramatic presentation of celiac disease
Authors: L. H. Rosenbaum
Journal: JAMA (1982)

A 72-YEAR-OLD man with diabetes mellitus of ten years' duration treated with diet and chlorpropamide experienced progressively disabling diarrhea after the eighth year. A life-threatening episode of hypoglycemia led to the eventual discovery of celiac disease as a cause for his diarrhea and to the recognition of the markedly increased sensitivity of the starved individual to the blood glucose-lowering action of this medication. The appearance of hypoglycemia in a patient with overt diabetes mellitus sufficient to cause coma and convulsions while receiving a standard dosage of an oral hypoglycemic agent must be considered an unusual event. <h3>Report of a Case</h3> A 72-year-old man had had typical symptoms of uncontrolled diabetes mellitus and a fasting blood glucose level of 450 mg/dL ten years previously. With correction of diet and the ingestion of 250 mg of chlorpropamide twice daily, his weight stabilized at a satisfactory level and nonfasting blood glucose levels measured
Manuscripts Approved for JNCI, October-November 1973
Journal: JNCI Journal of the National Cancer Institute (1973)

Journal Article Manuscripts Approved for JNCI, October-November 1973 Get access JNCI: Journal of the National Cancer Institute, Volume 51, Issue 6, December 1973, Pages 2038–2040, https://doi.org/10.1093/jnci/51.6.2038-a Published: 01 December 1973
Formation and Function of Children's Psychiatric Research Institute, London
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Thallium Poisoning
Authors: Millard Bass
Journal: JAMA (1965)

<h3>To the Editor:—</h3> In a recent paper I described a new treatment for thallium poisoning in humans (<i>J Amer Osteopath Assoc</i><b>63</b>:229-235 [Nov] 1963). The effectiveness of the agent, phosphate-buffered sodium diethylidithiocarbamate, in counteracting the lethal effects of thallium, has been impressive. The victim of an attempt at homicide with the rodenticide<i>thallium sulfate</i>was near death when therapy was started with buffered diethylidithiocarbamate (DEDC ). The solution of DEDC, a reduction product of disulfiram (antabuse), which is used in the treatment of alcoholism, was prepared for parenteral injection by adding 10 ml of a sterile solution of phosphate buffer (0.5 gm of sodium dihydrogen phosphate per 100 ml) to 1.0 mg of powdered DEDC. The resultant solution contained 100 μg of DEDC per ml. Dosage was calculated on the basis of 25 mg/kg of body weight. On the first day of therapy, 1.7 gm of DEDC was added to
Medical Schools in Canada
Journal: JAMA (1997)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs
Authors: Carlo Patrono, Paola Patrignani, Luis A. García Rodríguez
Journal: Journal of Clinical Investigation (2001)

Table 1 Incidence rates of major events possibly prevented or caused by COX inhibitors, as assessed in observational studies among non-users Event Incidence rate per 1,000 patient-years Heart failure 2-4 Myocardial infarction 1-4 Upper GI bleeding/perforation 0.6-1.7 Colorectal cancer 0.4-0.7 Acute renal failure 0.02-0.08